(Precision Vaccinations News)Developed by Chengdu Weisjin Biomedical Technology Co., Ltd. (Wesjin Biotech), WGc-043 is an mRNA therapeutic cancer vaccine that recently received IND approval from the U.S. Food and Drug Administration (FDA). According to …

Once commercialised, the mRNA therapeutic cancer vaccine will offer a new option to treat advanced Epstein–Barr virus-positive solid tumours and haematologic malignancies. The US Food and Drug Administration (FDA) has granted the first approval of an …

… autoimmune diseases (eg, multiple sclerosis and systemic lupus erythematosus). … -mrna-therapeutic-cancer-vaccine-receives-fda-approval- … ;personalized-mrna-cancer-vaccine-with-pembrolizumab-significantly- … -who-receive-enhanced-vaccine-experience-improvements-in …

Editor's note: An earlier version of this story incorrectly stated that the FDA had approved WGc-043. The FDA has approved the Investigational New Drug (IND) application for the vaccine. The FDA has approved the IND for WGc-043, the first and only …

Breaking News Offers new hope to patients with advanced EB virus-related cancers. 05.10.24 WestGene, a biotech company dedicated to mRNA technology, has received FDA IND approval for its mRNA therapeutic cancer vaccine, WGc-043—marking the world's …

CHENGDU, China, May 10, 2024 /PRNewswire/ -- WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, WGc-043. This landmark achievement marks the …

To provide a new treatment option for patients with advanced EB virus-positive solid tumours WestGene, a China-based biotech company dedicated to mRNA technology, has announced a historic milestone with the US FDA IND approval of its mRNA therapeutic …

In two months, countries from around the world will send athletes to France to compete in the 2024 Summer Olympics. But this week in Paris is all about lighting the torch for big business. At the “Choose France” summit, biopharma heavyweights are clocking …

The pharma industry’s growth prospects look promising thanks to favorable government initiatives, rising healthcare expenditures, the growing need for quality healthcare and personalized treatments, and the rise in lifestyle-related diseases. Amid this …

The emerging class of therapies that treat disease by using the cellular process of protein degradation focused first on cancer. But this approach also has potential applications in immunology, and Lycia Therapeutics is among the companies taking protein …